GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (NAS:IMCC) » Definitions » YoY EBITDA Growth

IMCC (IM Cannabis) YoY EBITDA Growth : -142.64% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is IM Cannabis YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. IM Cannabis's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -142.64%.

IM Cannabis's EBITDA per Share for the three months ended in Dec. 2024 was $-0.28.

IM Cannabis YoY EBITDA Growth Historical Data

The historical data trend for IM Cannabis's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis YoY EBITDA Growth Chart

IM Cannabis Annual Data
Trend Apr14 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -252.53 160.80 -296.15 90.16 -88.69

IM Cannabis Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.14 -714.98 -269.59 68.26 -142.64

IM Cannabis YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

IM Cannabis's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-1.836--0.973)/ | -0.973 |
=-88.69 %

IM Cannabis's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.278-0.652)/ | 0.652 |
=-142.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IM Cannabis YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of IM Cannabis's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

IM Cannabis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (NAS:IMCC) » Definitions » YoY EBITDA Growth
Comparable Companies
XCNQ:XBRA XCNQ:PWR TSXV:DHB XCNQ:HERB XCNQ:SE XCNQ:RIPP XCNQ:AION XCNQ:AYUR TSXV:MPH XCNQ:FFNT ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
IMCC:Canada
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
Website
https://www.imcannabis.com
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.